Parsons Co. (NYSE:PSN) Shares Bought by Qsemble Capital Management LP

Qsemble Capital Management LP increased its position in shares of Parsons Co. (NYSE:PSN) by 41.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,970 shares of the company’s stock after purchasing an additional 2,638 shares during the quarter. Qsemble Capital Management LP’s holdings in Parsons were worth $930,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of PSN. V Square Quantitative Management LLC acquired a new stake in Parsons during the 3rd quarter valued at approximately $33,000. Tanglewood Legacy Advisors LLC purchased a new stake in Parsons in the second quarter valued at $44,000. Capital Performance Advisors LLP purchased a new position in shares of Parsons during the 3rd quarter valued at about $45,000. DekaBank Deutsche Girozentrale acquired a new position in shares of Parsons in the 3rd quarter valued at about $72,000. Finally, Blue Trust Inc. grew its holdings in Parsons by 23.6% during the second quarter. Blue Trust Inc. now owns 1,041 shares of the company’s stock worth $86,000 after acquiring an additional 199 shares during the period. Hedge funds and other institutional investors own 98.02% of the company’s stock.

Parsons Stock Down 0.4 %

Shares of NYSE:PSN opened at $96.37 on Wednesday. The business has a fifty day moving average of $104.81 and a two-hundred day moving average of $91.21. The company has a quick ratio of 1.55, a current ratio of 1.55 and a debt-to-equity ratio of 0.47. The stock has a market cap of $10.23 billion, a P/E ratio of 146.01, a PEG ratio of 1.73 and a beta of 0.80. Parsons Co. has a 52-week low of $61.10 and a 52-week high of $114.68.

Parsons (NYSE:PSN) last issued its earnings results on Wednesday, October 30th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.73 by $0.07. The company had revenue of $1.81 billion for the quarter, compared to the consensus estimate of $1.63 billion. Parsons had a net margin of 1.21% and a return on equity of 12.74%. On average, research analysts expect that Parsons Co. will post 3.02 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on PSN shares. Benchmark boosted their price target on Parsons from $68.00 to $101.00 and gave the company a “buy” rating in a report on Thursday, August 1st. Truist Financial lowered their price target on shares of Parsons from $130.00 to $110.00 and set a “buy” rating on the stock in a report on Friday, November 22nd. KeyCorp upped their price objective on shares of Parsons from $116.00 to $122.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. Robert W. Baird raised their target price on Parsons from $103.00 to $125.00 and gave the company an “outperform” rating in a research report on Thursday, October 31st. Finally, Raymond James downgraded Parsons from a “strong-buy” rating to an “outperform” rating and set a $115.00 price target on the stock. in a research report on Wednesday, October 23rd. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, Parsons has a consensus rating of “Moderate Buy” and a consensus price target of $105.13.

Parsons Profile

Parsons Corporation provides integrated solutions and services in the defense, intelligence, and critical infrastructure markets in North America, the Middle East, and internationally. The company operates through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment provides critical technologies, such as cybersecurity; missile defense; intelligence; space launch and ground systems; space and weapon system resiliency; geospatial intelligence; signals intelligence; environmental remediation; border security, critical infrastructure protection; counter unmanned air systems; biometrics and bio surveillance solutions to U.S.